Celularity CELU 深 滬

Celularity Partners with Vesalius on U.S. Peptide Manufacturing

An update from Celularity ( ($CELU) ) is now available. On October 29, 2026, Ce...

10-29 21:47

Celularity Enters Manufacturing Agreement With Vesalius For Its Peptual-Branded Peptide Active Pharmaceutical Ingredients

Deal to establish a dedicated, first-of-its-kind, U.S. final stage API manufacturing and supply platform for Vesalius’s Peptual-branded active pharmaceutical ingredients ("APIs"). The collaboration expands Celularity’s regenerative longevity platform by applying Celularity’s U.S.-based manufacturing...

10-29 21:02

Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement

Celularity Inc. (Nasdaq: CELU) has regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its second-quarter 2026 Form 10-Q on October 20, 2026. This resolves a reporting deficiency, following previous compliance with minimum bid price and market value requirements. CEO Robert J. Hariri acknowledged past delays and emphasized the need to overhaul the finance organization to ensure timely reporting. The company is focused on building...

10-22 12:00

Celularity adds Naveen Jain amid strategic recapitalization

Celularity ( ($CELU) ) just unveiled an update. On Sept. 29, 2026, Celularity a...

09-30 05:49

Celularity Q1 EPS $0.02 Up From $(0.84) YoY, Sales $3.846M Down From $11.426M YoY

Celularity (NASDAQ:CELU) reported quarterly earnings of $0.02 per share. This is a 102.38 percent increase over losses of $(0.84) per share from the same period last year. The company reported $3.846 million in sales this quarter. This is a 66.34 percent decrease over sales of $11.426 million the sa...

09-30 05:32

Celularity Announces Initial Closing Generating Over $10M In Gross Cash Proceeds From Private Placement Of Senior Secured Convertible Notes And Warrants

Plan combines up to $25 million in new capital with restructuring of $3 million in existing debt to support commercial execution and manufacturing expansion Company anticipates positive monthly operating cash flow by the end of Q1 2027 Philip A. Barach to join the Board, bringing financial expertise...

09-24 21:17

Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements

09-24 13:15

Celularity Restores Nasdaq Compliance on Key Listing Standards

Celularity ( ($CELU) ) has provided an update. On September 11, 2026, Celularit...

09-14 21:29

Why Is Celularity Stock Gaining Thursday?

Celularity Inc. (NASDAQ:CELU) stock surged Thursday after the company announced a U.S. manufacturing collaboration with MuseCell Innovations. Under the agreement, Celularity will work to establish U.S. production of Dezawa MuseCells at its facility in Florham Park, New Jersey. Deal Could Expand The ...

08-28 01:42

Celularity shares are trading higher after the company announced an additional U.S.-based manufacturing collaboration under which Celularity will undertake activities to establish U.S. production of Dezawa MuseCells at Celularity’s Florham Park, New Jersey facility.

Celularity shares are trading higher after the company announced an additional U.S.-based manufacturing collaboration under which Celularity will undertake activities to establish U.S. production of Dezawa MuseCells at Celularity’s Florham Park, New Jersey facility.

08-27 22:18